Skip to main content

5 Result(s)

within D. Reimer Remove this filter English Remove this filter Oncology Remove this filter

and

  1. Article

    Open Access

    Intra- and postoperative catumaxomab in patients with epithelial ovarian cancer: safety and two-year efficacy results from a multicentre, single-arm, phase II study

    This is the first study investigating the safety and efficacy of the trifunctional antibody catumaxomab administered i.p. at the end of cytoreductive surgery and postoperatively prior to standard chemotherapy ...

    J Sehouli, A Reinthaller, C Marth, D Reimer, T Reimer… in British Journal of Cancer (2014)

    Download PDF (279 KB) View Article

  2. No Access

    Article

    Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer

    Recently we showed an integral epidermal growth factor receptor (EGFR)–E2F3a signaling path, in which E2F3a was found to be essential in EGFR-mediated proliferation in ovarian cancer cells. The present work ev...

    D Reimer, M Hubalek, H Kiefel, S Riedle, S Skvortsov, M Erdel, G Hofstetter… in Oncogene (2011)

  3. No Access

    Article

    Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer

    Similar to p73, the tumor suppressor gene p53 is subject to alternative splicing. Besides p53ΔE6 and p53β, we identified p53ζ, p53δ and p53ɛ, arising from alternative splicing of exon 6 and intron 9, respectively...

    G Hofstetter, A Berger, H Fiegl, N Slade, A Zorić, B Holzer, E Schuster… in Oncogene (2010)

  4. No Access

    Article

    Latest progress in treatment of gynaecological cancers

    The present report gives the scope of relevant contributions focusing on the treatment of gynaecologic malignancies presented at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) held...

    A. G. Zeimet, D. Reimer, C. Marth in memo - Magazine of European Medical Oncology (2008)

  5. No Access

    Article

    Primary chemotherapy and maintenance therapy in epithelial ovarian cancer

    PURPOSE. This overview summarizes the most prominent data on the evolution of first-line and maintenance chemotherapy in epithelial ovarian cancer. METHODS. The literature published on first-line and maintenan...

    A. G. Zeimet, D. Reimer, N. Concin, S. Braun… in memo - Magazine of European Medical Oncolo… (2008)